Mylan launches generic Avodart(R) capsules
Mylan announced the U.S. launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart® Capsules. Mylan received final FDA approval for its AANDA for this product, which is indicated as monotherapy for treatment of symptomatic BPH in men with an enlarged prostate. June 24, 2016